Breathe Life Sciences (BXN:ASX) Revenue

Biotechnology Research • Brisbane, Queensland, Australia • 21-50 Employees

Breathe Life Sciences (BXN:ASX) revenue & valuation

Annual revenue	$3,336,645
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$10,700,000
Total funding	No funding

Key Contacts at Breathe Life Sciences (BXN:ASX)

Gavin Ogilvie

Director

Natalia Satya Chua

Acting Head Of Production. Deputy Head Of Quality. Gmp. Chief Pharmacist/Pharmacist Manager

Sam Watson

Chief Executive Director

Jake Oshea

Deputy Head Of Production

Macdarragh O'

Head Of Production & Director

Company overview

Headquarters	Brisbane, Queensland, Australia
Website	breathelifesciences.com
Keywords	Skin Care, Clinical Trials, Telemedicine, Research & Development, Import, Export, Manufacture, Health Supplements, CBD, Medical Cannabis, Nootropics, Psilocybin, Medicine Technology, Chain Of Custody, Pharmaceutical Gmp, White Label Manufacture
Founded	2018
Employees	21-50
Socials

Breathe Life Sciences (BXN:ASX) Email Formats

Breathe Life Sciences (BXN:ASX) uses 4 email formats. The most common is {first initial} (e.g., j@breathelifesciences.com), used 45.8% of the time.

Format	Example	Percentage
{first initial}	j@breathelifesciences.com	45.8%
{first name}	john@breathelifesciences.com	41.7%
{first name}.{last name}	john.doe@breathelifesciences.com	8.3%
{first initial}.{last name}	j.doe@breathelifesciences.com	4.2%

About Breathe Life Sciences (BXN:ASX)

Breathe Life Sciences (BXN:ASX) is an Australian multi-national life sciences company focused on research, development, manufacture, and wholesale of novel pharmaceuticals, medicinal cannabis, psilocybin, consumer health and lifestyle products. In 2023 BLS was acquired by Bioxyne (BXN:ASX). The merged group has head offices in Sydney, London, Prague, and Nagoya. The Company operates in Australia, the United Kingdom, Germany, France, Czechia, Japan, and the United States. https://bioxyne.com/

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Head

Employees by Department

Breathe Life Sciences (BXN:ASX) has 19 employees across 8 departments.

Departments

Number of employees

Funding Data

Breathe Life Sciences (BXN:ASX) has never raised funding before.

Breathe Life Sciences (BXN:ASX) Tech Stack

Discover the technologies and tools that power Breathe Life Sciences (BXN:ASX)'s digital infrastructure, from frameworks to analytics platforms.

Site Kit

Analytics

iubenda

Cookie compliance

jQuery UI

JavaScript libraries

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HubSpot Analytics

Analytics

LiteSpeed

Web servers

HTTP/3

Miscellaneous

Frequently asked questions

Breathe Life Sciences (BXN:ASX) is located in Brisbane, Queensland, AU.

Breathe Life Sciences (BXN:ASX) generates an estimated annual revenue of $3,336,645. This revenue figure reflects the company's market position and business performance in its industry.

Breathe Life Sciences (BXN:ASX) has an estimated valuation of $10,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Breathe Life Sciences (BXN:ASX) was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Breathe Life Sciences (BXN:ASX) has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Breathe Life Sciences (BXN:ASX)

Gavin Ogilvie

Director

Natalia Satya Chua

Acting Head Of Production. Deputy Head Of Quality. Gmp. Chief Pharmacist/Pharmacist Manager

Sam Watson

Chief Executive Director

Jake Oshea

Deputy Head Of Production

Macdarragh O'

Head Of Production & Director

4.8